Tarsus Pharmaceuticals is on a mission to find the areas of high unmet need, where many people are suffering due to lack of approved treatments, and to develop the drugs that will help transform the lives of these patients. They've created a novel topical therapeutic “TP-03,” a first-in-class drug to treat Demodex Blepharitis.
Prime the industry for launch while potentially getting lost in a sea of sameness in the eye care space.
Break away from the norm and harness the power of their "indie pharma" mindset to chart new paths and areas of inspiration for patients, ECPs and investors. Our Strategy: Shift the branding to embrace the unorthodox while pushing the brand to live at the intersection of science and beauty.
Shift the branding to embrace the unorthodox while pushing the brand to live at the intersection of science and beauty.
